:

Ying Zhou1, Yi-Wen Sun1, Xiao-Yang Liu1

  • 1Department of Pathology, Peking University People's Hospital, Beijing 100044, China.

PubMed
概括

主要卵巢血管肉瘤 (OAS) 是罕见的. 像PD-1疗法这样的分子标记物和免疫检查点抑制剂为卵巢血管肉瘤患者的生存改善提供了新的治疗策略.